Study Links Daily Coffee Consumption to Lower Liver Disease Risk

A large U.S. cohort study involving 355,000 participants found that regular coffee drinking is associated with a reduced risk of serious liver conditions. Compared with non‑drinkers, people who consumed 1–2 cups a day had about a 20% lower chance of developing cirrhosis, a 24% lower risk of liver cancer and a 31% reduction in liver‑related death. Those drinking 3–4 cups saw risk reductions of roughly 35% for cirrhosis and cancer and a 41% drop in mortality, while intake of five or more cups cut cirrhosis risk by 32%, liver cancer by 47% and death by 42%. The protective effect was observed for both caffeinated and decaffeinated coffee, suggesting antioxidant compounds rather than caffeine drive the benefit. Imaging and blood‑test data also showed less liver fat, inflammation and fibrosis among coffee consumers. Experts note the findings are statistical associations, advise moderate intake (up to 400 mg caffeine per day), and recommend avoiding excess sugar, cream or artificial sweeteners that could offset the advantages.